The clinical significance of the detection of serum hs-CRP and interleukin-17 in senium type 2 diabetes with macroangiopathy
Rui Li
Abstract
Rui Li
Abstract
Objective To explore the relationship between serum hs-CRP,IL-17 levels and senium type 2 diabetic macrovascular complications and its clinical significance. Methods The serum levels of hs-CRP and IL-17 were measured with immunoturbidimetry and ELISA respectively in 80 cases of type 2 diabetic patients with macrovascular complications,80 cases of the absence of any major vascular complications in patients with type 2 diabetes and 80 healthy subjects as the control. Results The serum hs-CRP and IL-17 levels of senium type 2 diabetic Patients with macrovascular complications were significantly higher than those of patients without macrovascular complication and healthy control group(t=19.18,23.14,all P 0.05); In patients of type 2 diabetic Patients with macrovascular complications,hs-CRP was positively correlated with serum IL-17(r=0.712,P<0.05). Conclusion Hs-CRP and IL-17might be involved in the process of inflammatory response to diabetic macroangiopathy, and may have important role in the pathogenesis of senium type 2 diabetic patients with macrovascular complications. Detemination of hs-CRP and IL-17 levels in type 2 diabetic patients may be useful for early detecting diabetic macrovascular complications and serve as the index in monitoring the state of diabetic macrovascular complications. Key words: Diabetes mellitus, type 2; Diabetic Angiopathies; Interleukin-17; C-Reactive Protein; Aged
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the relationship between serum hs-CRP,IL-17 levels and senium type 2 diabetic macrovascular complications and its clinical significance. Methods The serum levels of hs-CRP and IL-17 were measured with immunoturbidimetry and ELISA respectively in 80 cases of type 2 diabetic patients with macrovascular complications,80 cases of the absence of any major vascular complications in patients with type 2 diabetes and 80 healthy subjects as the control. Results The serum hs-CRP and IL-17 levels of senium type 2 diabetic Patients with macrovascular complications were significantly higher than those of patients without macrovascular complication and healthy control group(t=19.18,23.14,all P 0.05); In patients of type 2 diabetic Patients with macrovascular complications,hs-CRP was positively correlated with serum IL-17(r=0.712,P<0.05). Conclusion Hs-CRP and IL-17might be involved in the process of inflammatory response to diabetic macroangiopathy, and may have important role in the pathogenesis of senium type 2 diabetic patients with macrovascular complications. Detemination of hs-CRP and IL-17 levels in type 2 diabetic patients may be useful for early detecting diabetic macrovascular complications and serve as the index in monitoring the state of diabetic macrovascular complications. Key words: Diabetes mellitus, type 2; Diabetic Angiopathies; Interleukin-17; C-Reactive Protein; Aged
Key concepts: Medicine, Internal medicine, Type 2 diabetes, Diabetes mellitus, Diabetic angiopathy, Gastroenterology, Endocrinology